Business Wire

GA-FARM-TO-PLATE

28.2.2023 21:34:42 CET | Business Wire | Press release

Share
Farm to Plate Announces the Availability of Revolutionary Supply Chain SaaS Platform to Elevate Food Safety, Minimize Recalls and Drive Sustainable Ecosystems

Today, Farm to Plate announced the immediate availability of Farm To Plate (F2P), a pioneering blockchain-based provenance and tracking product for the Food supply chain that will expand the scope of data transparency to the grassroots of the food industry – end-to-end, from the producers to the consumers. The Farm to Plate platform addresses increased regulatory demands for digitization and transparency through GS1 and FDA FSMA Rule #204 compliance and heightens brand trust, financial stability, and reputation by enabling a focus on sustainability, responsible farming, consumer transparency, and significantly reduced recall risk and size. See how it works.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006317/en/

Key Features and Benefits of Farm to Plate

  • Microtipping: Enables direct tips to producers from end consumers that are securely, instantaneously transmitted over the blockchain, eliminating middlemen and chances of fraud while giving producers a great boost to their meager revenues.
  • Immutable, end-to-end tracking and trace: Immutable, decentralized information ensures no single stakeholder has disproportionate information ownership, eliminating the risk of data fudging.
  • Secure access control for information on the blockchain: Strong access controls enable granular control over who has access to what data, ensuring only relevant, required information is accessible to different parties.
  • Built on GS1 standards and compliant with FDA FSMA Rule #204.

Fulfilling Consumers’ Need for End-to-end Transparency

In a globalized food supply chain where food is sourced and transported across continents, the level of transparency, from sourcing, transportation, to storage and other details, that consumers are now demanding is unprecedented. Research also proves that 73% of consumers prefer brands that are sustainable, honest, and transparent about how and where products were raised or grown. Sustainable production is also high on their wishlist, with them being willing to pay a huge premium - anywhere from 30% to 40% on average – for sustainably produced goods. “Farm to Plate will be revolutionary for food brands looking to develop a strong identity with the sustainability-focused modern consumer. By enabling transparency and the ability to directly connect to their suppliers, brands can project a strong image as a modern, conscious corporation to their customers. This is the beginning of a long journey of trust between consumers and food brands.”- Mika Liss, Strategic Advisor, Farm To Plate.

Farm to Plate Fills the Missing Links in the Supply Chain

Food brands are struggling with the weight of regulatory requirements and the consumers’ transparency demands. Providing such in-depth and reliable information in a complex global supply chain poses challenges. There is heavy dependency on manual processes making data vulnerable to fraud and preventing timely information from passing to all stakeholders. Farm to Plate uses permissioned blockchain, AI-driven tools, and automation through IoT devices to provide access-controlled, immutable, real-time data to the right stakeholders. “We’ve built F2P with open, industry-standard technology that integrates seamlessly with your existing systems. And the best part about it is, it’s modular, allowing us to extend its capabilities almost infinitely as we build out features in future releases.”- Saptarshi Choudhury, VP of Product at Farm To Plate.

Connecting Consumers and Farmers for Sustainable Ecosystems

Through innovative use of popular messaging platforms such as WhatsApp, voice transcription, vernacular language translations and offline functionality, Farm To Plate is the first track and trace solution truly accessible to the fisherman and farmer. Through microtipping, Farm to Plate will leverage the consumer-farmer connection to bring financial stability to the producer community and reduce the risk of overfarming.

“Farm To Plate is the first food supply chain solution that will connect every stakeholder to the other, and make them part of the system. Uniquely, we connect consumers and farmers directly - enabling consumer food trust through transparency and financial sustainability for producers through a single QR code. Our value proposition is enshrined in the 5 Ts: Trace, Track, Trade, Tip, Trust – and Tip is our favorite because it acknowledges the farmer.”- Pramod Sajja, President and CEO, Farm to Plate LLC. & Paramount Software Solutions Inc.

About Farm to Plate

The vision of the Blockchain team of Farm to Plate was to develop a product to transform the way the food and beverage industry operates. The success stories of Hyperledger Fabric resulted in its adoption to enable bringing the open-source ecosystem to the forefront of this technology. Farm to Plate wanted to build something that made a difference, and yet simple to adapt to fill the gaps in the existing food supply chain systems.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006317/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye